伯特-霍格-杜布综合征诊断与管理专家共识
本共识由全国相关领域专家制定,针对罕见常染色体显性遗传病伯特-霍格-杜布综合征(BHD),通过投票形成15条推荐意见,涵盖临床评估、诊断标准、鉴别诊断、治疗、随访及家系管理,并基于中国国情修订了诊断标准。
要点
- BHD综合征以弥漫性肺部囊状病变和气胸为主要表现,肾脏和皮肤受累在中国人群中相对少见。
- 疑似BHD患者应行胸部CT评估肺部囊性病变,并常规评估肾脏肿瘤,可选用超声、增强CT或MR。
- BHD综合征需特别与其他弥漫性囊性肺疾病鉴别,如淋巴管肌瘤病、淋巴细胞间质性肺炎、肺朗格汉斯细胞组织细胞增生症等。
核心结论
- 本共识通过15条推荐意见规范BHD综合征的临床评估、诊断、鉴别诊断、治疗、随访和家系管理,并基于中国国情优化了诊断标准,旨在推动规范诊疗和科学研究,改善患者预后。
研究设计与样本
- 由全国相关领域专家制定的专家共识,通过投票形成15条推荐意见,投票专家43名,各推荐意见赞成票为43票或42票,反对票均为0票,弃权票为0票或1票;共识提供了基于中国国情的修订诊断标准。
关键影像表现/征象
- BHD综合征的肺部表现为弥漫性囊状病变,常导致自发性气胸。
- 皮肤病变为纤维毛囊瘤或毛盘瘤,肾脏病变为多种类型的肾脏肿瘤。
- 与欧美高加索人群比较,中国人群BHD综合征多累及肺部,肾脏和皮肤受累相对少见。
诊断标准与关键数值
- 临床诊断应基于适当的临床表现,并结合基因检测结果和/或BHD综合征家族史。
- FLCN基因是目前唯一确认的BHD综合征致病基因,基因检测方法包括Sanger测序、多重连接依赖探针扩增(MLPA)和二代测序(NGS),可根据患者个体化医疗需求选择。
- 疑似BHD综合征患者,基于临床和肺部影像学表现,不推荐将肺组织病理活检作为首选。
- BHD综合征合并肾肿瘤:肿瘤直径<1 cm时推荐每年行腹部MR检查;肿瘤直径1-3 cm时推荐每6个月行腹部MR检查或消融手术;肿瘤直径>3 cm时推荐保留肾功能的肾肿瘤局部切除术。
临床应用与阅片要点
- BHD综合征患者应行胸部CT扫描评估肺部囊性病变,并常规评估肾脏肿瘤病灶,可酌情选用超声、增强CT或MR。
- BHD综合征需特别与其他弥漫性囊性肺疾病鉴别,如淋巴管肌瘤病(LAM)、淋巴细胞间质性肺炎(LIP)、肺朗格汉斯细胞组织细胞增生症(PLCH)等。
- BHD综合征临床罕见且常涉及多学科,推荐多学科讨论以提高诊断水平。
- BHD综合征患者应避免吸烟,推荐接种流感疫苗、肺炎球菌疫苗和SARS-Cov-2疫苗以预防感染。
- BHD综合征患者发生气胸后,在气胸恢复前不推荐乘坐飞机。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Birt-Hogg-Dubé syndrome (BHD) is a rare autosomal dominant disorder characterized by diffuse pulmonary cysts often leading to recurrent spontaneous pneumothorax, cutaneous fibrofolliculomas or trichodiscomas, and a variety of renal cell cancers. It is caused by pathogenic variants in the FLCN gene located on chromosome 17p11.2. Although an increasing number of patients with BHD syndrome are being recognized in China, the missed diagnosis and delayed diagnosis are still common. In addition, appropriate management is difficult for most of them. Pulmonary cysts and pneumothorax are the main presenting features, but skin and renal lesions appear to be less common in Chinese subjects than those reported from European and American countries. Therefore, the consensus is established by experts from the related disciplines to improve the diagnosis and management of BHD syndrome. This consensus consists of 15 recommendations related to BHD syndrome, including clinical assessments, diagnosis, differential diagnosis, treatment, follow-up, and family management. In particular, it provides revised diagnostic criteria based on the Chinese situation. We hope to promote scientific and clinical progress in this rare disease and improve the prognosis of the patients.Summary of recommendations[Recommendation 1] The folliculin (FLCN) gene is currently the only affirmative causative gene for Birt-Hogg-Dubé (BHD) syndrome, and the pedigree analysis of genetic testing of family members' samples can assist in the rapid identification of causative gene variants. The genetic testing methods, including Sanger sequencing, Multiplex Ligation-dependent Probe Amplification (MLPA), and Next-Generation Sequencing (NGS), can be chosen based on individual patient's care needs. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 2] Patients with BHD syndrome should undergo chest CT scan to evaluate cystic lesions in the lungs, and routine evaluation of the kidneys for tumor foci, using ultrasound, enhanced CT, or MR as appropriate. (43 experts voted; 43 in favor, 0 against, 0 abstention).[Recommendation 3] Clinicians should establish a diagnosis based on the appropriate clinical presentation and in conjunction with genetic test results and/or a family history of BHD syndrome. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 4] Lung histopathological biopsy is not recommended as the first choice for patients with suspected BHD syndrome based on clinical and pulmonary imaging manifestations. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 5] BHD syndrome should be particularly distinguished from other diffuse cystic lung diseases, such as lymphangioleiomyomatosis (LAM), lymphocyte interstitial pneumonia (LIP), pulmonary Langerhans cell histiocytosis (PLCH), etc. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 6] BHD syndrome is clinically rare and often involves multiple disciplines, such as respiratory and critical care medicine, radiology, pathology, thoracic surgery, urology, genetics, and dermatology, and multidisciplinary discussions are recommended to improve the diagnosis of BHD syndrome. (43 voting experts; 43 in favor, 0 against, 0 abstentions).[Recommendation 7] Patients with BHD syndrome should avoid smoking, and are recommended to be vaccinated with influenza, pneumococcal, and SARS-Cov-2 vaccines to prevent infections. (43 voting experts; 43 in favor, 0 against, 0 abstentions).[Recommendation 8] Air travel is not recommended for patients with BHD syndrome who have experienced pneumothorax until it has been recovered. (43 voting experts; 42 in favor, 0 against, 1 abstention).[Recommendation 9] In patients with BHD syndrome complicated by pneumothorax, early pleurodesis is recommended to reduce the risk of recurrence. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 10] Observation or topical treatment may be chosen for patients with BHD syndrome complicated by fibrofolliculoma or trichodiscoma. (43 voting experts; 42 in favor, 0 against, 1 abstention).[Recommendation 11] For patients with BHD syndrome complicated by renal tumors, annual abdominal MR examination is recommended when tumors are <1 cm in diameter; when tumors are 1-3 cm in diameter, abdominal MR examination at every 6 months or ablation surgery is recommended; when renal tumors are >3 cm in diameter, local excision of renal tumors with preservation of renal function is recommended. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 12] Patients with BHD syndrome are associated with significantly increased risks of kidney cancer, and routine screenings of kidney cancer during their lifetime are recommended. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 13] Couples with BHD syndrome are advised to undergo prenatal genetic counseling when preparing for pregnancy, to work with a prenatal diagnostician to assess genetic risk, and to discuss the feasibility of prenatal diagnosis during pregnancy. (43 experts voted; 43 in favor, 0 against, 0 abstention).[Recommendation 14] Family members of patients with BHD syndrome should receive health education, and FLCN gene testing is recommended for asymptomatic adults to rule out BHD syndrome in a timely manner. (43 voting experts; 43 in favor, 0 against, 0 abstention).[Recommendation 15] Improvements in the clinical diagnosis and treatment of BHD syndrome and overall management are needed. Due to the scarcity of effective therapeutic drugs, multicenter, prospective clinical trials are recommended. (43 experts voted; 43 in favor, 0 against, 0 abstention).
伯特-霍格-杜布综合征(Birt-Hogg-Dubé syndrome,BHD)是一种罕见的常染色体显性遗传性疾病,其临床特征为弥漫性肺部囊状病变、自发性气胸、皮肤纤维毛囊瘤或毛盘瘤和多种类型的肾脏肿瘤。BHD综合征发病机制与第17号染色体的卵泡素蛋白(folliculin,FLCN)相关基因功能丢失变异有关。近年来我国BHD综合征病例报道数量逐年攀升,与欧美高加索人群比较,BHD综合征中国人群多累及肺部,主要呈弥漫性囊状病变并常导致气胸,而肾脏和皮肤受累相对少见,故临床上漏诊和误诊较普遍,缺乏规范诊疗与科学管理。为进一步提高BHD综合征诊治和管理水平,特邀请全国相关领域专家制定本专家共识。本共识通过投票形成15条专家推荐意见,具体包括临床评估、诊断标准、鉴别诊断、治疗、随访以及家系管理等,特别是根据我国实际国情,优化了诊断标准。旨在通过本专家共识,推动BHD综合征规范诊疗和科学研究,改善患者预后。.
引用
- [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome]. Zhonghua Jie He He Hu Xi Za Zhi. 2023. PMID: 37670643. doi:10.3760/cma.j.cn112147-20230705-00362
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。